MedTrace Logo

Outpatient Ultrafiltration Therapy in Heart Failure Patients Trial

NCT00319384 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-10-04

No results posted yet for this study

Summary

This trial will look at the effectiveness and patient acceptance of ultrafiltration therapy in an outpatient setting.

The purpose of this study is to determine if ambulatory patients who suffer from heart failure and hypervolemia can be safely and effectively treated in an outpatient infusion clinic. The results from this trial will be useful in planning a larger, randomized trial comparing usual care and ultrafiltration for this patient population in similar ambulatory settings.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

Ultrafiltration therapy

Sponsors & Collaborators

  • Nuwellis, Inc.

    collaborator INDUSTRY

  • Hennepin Healthcare Research Institute

    lead OTHER

Principal Investigators

  • Bradley Bart, MD · Hennepin Faculty Associates

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Completion
2007-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00319384 on ClinicalTrials.gov